Publication | Open Access

Mortality and Hospitalization Risk Following Oral Androgen Signaling Inhibitors Among Men with Advanced Prostate Cancer by Pre-existing Cardiovascular Comorbidities

UrologyHealth PolicyCardiovascular DiseaseMedicineEpidemiology Of CancerPre-existing Cardiovascular ComorbiditiesAdvanced Prostate CancerPharmacotherapyProstatic DiseasePublic HealthCardiovascular ToxicityOncologyRadiation Oncology